nephrolithiasis such as Burst Wave Lithotripsy (BWL) will require in vitro testing to identify appropriate output parameters. To create a more clinically relevant model, we investigated the effects of fluid gas concentration, temperature, stone holder, and model stone composition on fragmentation.
INTRODUCTION AND OBJECTIVES: The Modulith SLK-F2
Electromagnatic lithotripter (Storz Medical AG, T€ agerwilen, Switzerland) is the first lithotripter on the market with a unique design that allows for a dual focus system with the option of either a narrow or wide focal zone. Ex vivo data on the SLK-F2 lithotripter shows that the disintegration capacity and the renal vascular injury are independent of the focal diameter of the SW generator at the same peak positive pressure and disintegration power. We report on a subset of patients from our larger randomized trial for whom data on markers of renal injury were available.
METHODS: A subset of 134 patients (out of 263 total patients randomized in the trial) with previously untreated radio-opaque solitary stone located within the renal collecting system, measuring at least 5mm, were randomized to receive narrow or wide focus lithotripsy while maintaining a constant overall energy level, and also collected urinary markers of renal injury. Patients were followed with renal ultrasound at 2 weeks post lithotripsy to assess for the development of perinephric hematoma. Urinary markers of renal cellular damage (microalbulin, creatinine, beta 2-microglobulin, microalbumin/creatinine ratio and Beta 2-microglobulin/creatinine ratio) were measured pre-SWL, immediately post-procedure in the recovery room, 24 hours post-SWL and 7 days post-treatment. Data was analyzed using ANOVA and repeated measures ANOVA, Chisquare statistic and linear regression where appropriate, controlling for presence of diabetes as a confounder.
RESULTS: 68 patients were randomized to narrow focus lithotripsy versus 66 patients to wide focus. The groups were similar in baseline characteristics including age, gender, BMI, stone size and density, skin to stone distance and diagnosis of diabetes. Overall complication rates were comparable between the two groups (Narrow: 23.5% vs Wide: 12.1% P¼0.085) including similar rates of perinephric hematoma (Narrow: 2.9% vs Wide: 4.5%; P ¼ 0.624) and Steinstrasse (Narrow: 7.4% vs Wide: 4.5%; P ¼ 0.493). Urinary markers of renal injury did change after SWL, and then normalized within 7days, however there were no differences in the magnitude, timing or degree of change between the narrow and wide focal zone groups.
CONCLUSIONS: The degree of renal injury as assessed by renal cellular markers and by ultrasound assessment of perinephric hematoma are comparable when using the narrow or wide focal zone of the Modulith SLX-F2. is the first lithotripter on the market with a unique design that allows for a dual focus system with the option of either a narrow or wide focal zone. Ex vivo data on the SLK-F2 lithotripter shows that disintegration capacity and renal vascular injury are independent of the focal diameter of the SW generator at the same peak positive pressure and disintegration power. The objective of this study is to compare the single-treatment success rates of narrow and wide focal zones for shock wave lithotripsy of renal stones.
METHODS: 263 patients, with a previously untreated >¼ 5 mm radio-opaque solitary stone located within the collecting system, were randomized to receive narrow or wide focus lithotripsy, while maintaining a constant overall energy level of 6. Patients were followed with KUB x-rays and renal ultrasound at 2 and 12 weeks post lithotripsy to assess stone area and stone free status. Primary outcome was success rate, defined as stone-free or adequate fragmentation (sand or asymptomatic fragments <¼4 mm) at 3 months following a single SWL treatment.
RESULTS: 130 patients were randomized to narrow focus lithotripsy versus 133 to wide focus lithotripsy. The groups were similar in baseline characteristics. The overall success rates were statistically different at 2 weeks post treatment (Narrow: 69.2% vs Wide: 57.1%; P ¼ 0.042) and also at 3 months (Narrow: 69.2% vs Wide: 57.1%; P ¼ 0.042). For smaller stones (area < 100 mm2) there was a greater benefit with narrow focus lithotripsy (72.6% vs 60.3%; P¼0.05). The SWL retreatment rate for the same stone within 3 months was significantly higher when Wide focus was used (44.4% vs 30.8%; P¼0.023). Overall the complication rates were comparable in both groups (Narrow: 23.3% vs Wide: 15.9%; P ¼ 0.135). However, the narrow group required significantly fewer ancillary procedures within the initial 3 month follow-up period (Narrow: 30.8% vs Wide: 42.9 %; P ¼ 0.042).
CONCLUSIONS: Narrow focus lithotripsy yields better outcomes than wide focus lithotripsy, particularly for stones < 100 mm2, with lower retreatment rates and without increased in morbidity.
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